Tolvaptan, hyponatremia, and heart failure

Overview of attention for article published in International Journal of Nephrology and Renovascular Disease, March 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#49 of 259)
Good Attention Score compared to outputs of the same age (79th percentile)

Mentioned by

twitter: 2 X users
patent: 5 patents

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 29 Dimensions

Readers on

mendeley: 48 Mendeley

Summary X Patents Wikipedia Dimensions citations

So far, Dimensions has found 29 publications that cite this research output.

29

The most recent citing publications are shown below. View all 29 publications that cite this research output on Dimensions.

Can tolvaptan usage cause cytotoxicity? An in vitro study

Article in The European Research Journal (May 2023)

Management of Hyponatremia in Heart Failure: Practical Considerations

Article in Journal of Personalized Medicine (January 2023)

A Case of Tolvaptan-Induced Osmotic Demyelination Syndrome Secondary to Correcting Hyponatremia: A Literature Review

Article in Advances in Clinical Medicine (January 2023)